Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases

Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months or even years. In persons who respond to megestrol, long term use can cause weight gain and other side effects via activity of the drug at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Read, William L., Trivedi, Sumita, Williams, Felicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647516/
https://www.ncbi.nlm.nih.gov/pubmed/29062884
http://dx.doi.org/10.1016/j.gore.2017.09.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647516/
https://www.ncbi.nlm.nih.gov/pubmed/29062884
http://dx.doi.org/10.1016/j.gore.2017.09.015

Ejemplares similares